Maya Beganovic

710 total citations
21 papers, 498 citations indexed

About

Maya Beganovic is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Maya Beganovic has authored 21 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Applied Microbiology and Biotechnology and 7 papers in Pharmacology. Recurrent topics in Maya Beganovic's work include Antibiotic Use and Resistance (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Maya Beganovic is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Bacterial Identification and Susceptibility Testing (7 papers). Maya Beganovic collaborates with scholars based in United States and Colombia. Maya Beganovic's co-authors include Kerry L. LaPlante, Megan K. Luther, Michael J. Rybak, Louis B. Rice, César A. Arias, Michael Costello, Aisling R. Caffrey, Tristan T. Timbrook, Haley J. Appaneal and Jessica L. Miller and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Maya Beganovic

19 papers receiving 488 citations

Peers

Maya Beganovic
Trusha Nana South Africa
Michael Bolaris United States
Jung-Jr Ye Taiwan
Simone M. Shurland United States
Warren Lowman South Africa
Trusha Nana South Africa
Maya Beganovic
Citations per year, relative to Maya Beganovic Maya Beganovic (= 1×) peers Trusha Nana

Countries citing papers authored by Maya Beganovic

Since Specialization
Citations

This map shows the geographic impact of Maya Beganovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maya Beganovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maya Beganovic more than expected).

Fields of papers citing papers by Maya Beganovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maya Beganovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maya Beganovic. The network helps show where Maya Beganovic may publish in the future.

Co-authorship network of co-authors of Maya Beganovic

This figure shows the co-authorship network connecting the top 25 collaborators of Maya Beganovic. A scholar is included among the top collaborators of Maya Beganovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maya Beganovic. Maya Beganovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Beganovic, Maya, James M. Kidd, Rachna Kapoor, et al.. (2022). The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic. Drug Safety. 46(2). 145–155. 8 indexed citations
3.
Whalen, Kristen E., Iván Álvarez-Freire, Maya Beganovic, et al.. (2021). Identification of a bacteria-produced benzisoxazole with antibiotic activity against multi-drug resistant Acinetobacter baumannii. The Journal of Antibiotics. 74(6). 370–380. 9 indexed citations
4.
Beganovic, Maya, et al.. (2021). Lactobacillus Endocarditis Complicated by Presumed Vertebral Osteomyelitis and Embolic Stroke. Infectious Diseases in Clinical Practice. 29(6). e418–e419. 1 indexed citations
5.
Miller, Jessica L., et al.. (2020). Clinical Outcomes of Patients Treated for Candida auris Infections in a Multisite Health System, Illinois, USA. Emerging infectious diseases. 26(5). 876–880. 37 indexed citations
7.
Miller, Jessica L., et al.. (2020). Impact of Mandatory Infectious Diseases Consultation and Real-time Antimicrobial Stewardship Pharmacist Intervention on Staphylococcus aureus Bacteremia Bundle Adherence. Open Forum Infectious Diseases. 7(6). ofaa184–ofaa184. 11 indexed citations
9.
Beganovic, Maya, et al.. (2019). Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii. Diagnostic Microbiology and Infectious Disease. 94(3). 223–226. 15 indexed citations
10.
Miller, Jessica L., et al.. (2019). Comparison of emergency department to hospital antibiograms: Influence of patient risk factors on susceptibility. The American Journal of Emergency Medicine. 38(6). 1153–1158. 1 indexed citations
11.
Beganovic, Maya, et al.. (2019). Introduction of Selection Biases Due to Loss to Follow-Up in Infectious Disease Retrospective Outcomes Studies. Antimicrobial Agents and Chemotherapy. 63(12). 1 indexed citations
12.
Appaneal, Haley J., et al.. (2019). Predictors of Clostridioides difficile recurrence across a national cohort of veterans in outpatient, acute, and long-term care settings. American Journal of Health-System Pharmacy. 76(9). 581–590. 20 indexed citations
14.
Beganovic, Maya & Kerry L. LaPlante. (2018). Communicating with Facility Leadership; Metrics for Successful Antimicrobial Stewardship Programs (Asp) in Acute Care and Long-Term Care Facilities.. PubMed. 101(5). 45–49. 4 indexed citations
15.
Appaneal, Haley J., et al.. (2018). Predictors of Mortality Among a National Cohort of Veterans With Recurrent Clostridium difficile Infection. Open Forum Infectious Diseases. 5(8). ofy175–ofy175. 24 indexed citations
16.
Beganovic, Maya, et al.. (2018). Predictors of Time to Effective and Optimal Antimicrobial Therapy in Patients With Positive Blood Cultures Identified via Molecular Rapid Diagnostic Testing. Open Forum Infectious Diseases. 6(1). ofy350–ofy350. 6 indexed citations
17.
Beganovic, Maya, Megan K. Luther, Louis B. Rice, et al.. (2018). A Review of Combination Antimicrobial Therapy for Enterococcus faecalis Bloodstream Infections and Infective Endocarditis. Clinical Infectious Diseases. 67(2). 303–309. 151 indexed citations
18.
Beganovic, Maya, et al.. (2018). Interplay between Rapid Diagnostic Tests and Antimicrobial Stewardship Programs among Patients with Bloodstream and Other Severe Infections. The Journal of Applied Laboratory Medicine. 3(4). 601–616. 24 indexed citations
19.
Timbrook, Tristan T., et al.. (2017). Assessments of Opportunities to Improve Antibiotic Prescribing in an Emergency Department: A Period Prevalence Survey. Infectious Diseases and Therapy. 6(4). 497–505. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026